Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
Wiener klinische Wochenschrift
Erschienen in:

01.12.2015 | original article

Ischemic stroke: the impact of renal dysfunction on 1-year mortality

verfasst von: Assoc. Prof. Tanja Hojs Fabjan, MD, PhD, Prof. Radovan Hojs, MD, PhD

Erschienen in: Wiener klinische Wochenschrift | Sonderheft 5/2015

Einloggen, um Zugang zu erhalten

Summary

Background

Atherosclerosis is accelerated in patients with different stages of chronic renal failure. Renal dysfunction predicts mortality in patients with myocardial infarction and congestive heart failure. Less is known about the impact of renal dysfunction on mortality after ischemic stroke. The aim of the study was to investigate the impact of renal dysfunction on 1-year mortality.

Patients and methods

All 390 patients (207 men and 183 women) suffered from ischemic stroke in 1-year period were included in our study. Telephonic follow-up after 1 year was performed. The mean age of our patients was 71.0 ± 11.6 years, ranged from 36 to 96 years. Glomerular filtration rate (GFR) was calculated according to abbreviated Modification of Diet in Renal Disease formula. At admission and at discharge National Institutes of Health Stroke Scale (NIHSS) were performed.

Results

The mean GFR in our patients was 66.0 ± 20.68 ml/min/1.73 m2. There were 123 (31.5 %) deaths in 1-year period. Patients who died were older (P < 0.001), had higher NIHSS at admission and at discharge (both P < 0.001), higher high-sensitive C-reactive protein (P = 0.002), lower albumin (P < 0.001), lower GFR (P = 0.044), had more frequent atrial fibrillation (P < 0.001), and were less frequent actual smokers (P = 0.003). No differences in presence of diabetes and hypertension, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and triglycerides between patients who died or survived were found. With Cox multivariable regression analysis age (P = 0.037), gender (P = 0.005), NIHSS at admission (P = 0.005) and discharge (P < 0.001), albumin (P = 0.005) and also GFR (P = 0.025) were predictors of 1-year mortality.

Conclusions

In patients with ischemic stroke, renal dysfunction (decreased GFR) was associated with 1-year mortality. GFR was independent predictor of mortality.
Vorheriger Artikel Influence of cataract surgery on macular thickness: a 6-month follow-up
Nächster Artikel Deterioration of renal function at stent implantation can predict long-term outcome after stent thrombosis
Literatur
1.
2.
US Renal Data System. USRDS 2008 Annual Data Report, Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease; 2008.
3.
London GM, Guėrin AP, Marchais SJ, et al. Cardiac and arterial interactions in end-stage renal disease. Kidney Int. 1996;50 (2):600–8.CrossRefPubMed
4.
Kawagishi T, Nishizawa Y, Konishi T, et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int. 1995;48(3):820–6.CrossRefPubMed
5.
Hojs R. Carotid intima-media thickness and plaques in hemodialysis patients. Artif Organs. 2000;24(9):691–5.CrossRefPubMed
6.
Foley RN, Parfrey PS, Sarnak MJ. The clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112–9.CrossRefPubMed
7.
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risk of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–305.CrossRefPubMed
8.
Kennedy R, Case C, Fahti R, Jihnson D, Isbel N, Marwick TH. Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease? Am J Med 2001;110(3):198–204.CrossRefPubMed
9.
Seliger SL, Gillen DL, Longstreth WT, et al. Elevated risk of stroke among patients with end-stage renal disease. Kidney Int. 2003;64(2):603–9.CrossRefPubMed
10.
Iseki K, Kinjo K, Kimura Y, et al. Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int. 1993;44(5):1086–90.CrossRefPubMed
11.
Sozio SM, Armstrong PA, Coresh J, et al. Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study. Am J Kidney Dis. 2009;54(3):468–77.CrossRefPubMedPubMedCentral
12.
Seliger SL. Stroke in ESRD: the other cardiovascular disease. Am J Kidney Dis. 2009;54(3):403–5.CrossRefPubMed
13.
Sanchez-Perales C, Vazquez E, Garcia-Cortes J, et al. Ischaemic stroke in incident dialysis patients. Nephrol Dial Transplant. 2010;25(10):3343–8.CrossRefPubMed
14.
Koren-Morag N, Goldbourt U, Tanne D. Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease. Neurology. 2006;67(2):224–8.CrossRefPubMed
15.
Tsagalis G, Akrivos T, Alevizaki M, et al. Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality. Nephrol Dial Transplant. 2009;24(1):194–200.CrossRefPubMed
16.
Schiele F, Legalery P, Didier K, et al. Impact of renal dysfunction on 1-year mortality after acute myocardial infarction. Am Heart J. 2006;151(3):661–7.CrossRefPubMed
17.
Naidu SS, Selzer F, Jacobs A, et al. Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. Am J Cardiol. 2003;92(10):1160–4.CrossRefPubMed
18.
Sadeghi HM, Stone GW, Grines CL, et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation. 2003;108(22):2769–75.CrossRefPubMed
19.
Bevc S, Penko M, Kanič V, Hojs R. Mortality of patients with renal dysfunction after percutaneus coronary intervention. Angiology. 2010;61(1):24–30.CrossRefPubMed
20.
Freiedman PJ. Serum creatinine: an independent predictor od survival after stroke. J Intern Med. 1991;229(2):175–9.CrossRef
21.
Hojs Fabjan T, Hojs R, Tetickovic E, Pecovnik Balon B. Ischaemic stroke—impact of renal dysfunction on in-hospital mortality. Eur J Neurol. 2007;14(12):1351–6.CrossRefPubMed
22.
MacWalter RS, Wong SYS, Wong KYK. Does renal dysfunction predict mortality after acute stroke?: A 7-year follow-up study. Stroke. 2002;33(6):130–5.CrossRef
23.
Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas AM, Schroll M. Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organisation Monitoring Trends and Determinants in Cardiovascular Disease. Stroke. 1995;26(3):361–7.CrossRefPubMed
24.
Muir KW, Weir CJ, Murray GD, Povey C, Lees KR. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke. 1996;27(10):1817–20.CrossRefPubMed
25.
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.
26.
Santopinto JJ, Fox KA, Goldberg RJ, et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart. 2003;89(9):1003–8.CrossRefPubMedPubMedCentral
27.
Walsh CR, OʼDonnell CJ, Camargo CA, Jr., Giugliano RP, Lloyd-Jones DM. Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction. Am Heart J. 2002;144(6):1003–11.CrossRefPubMed
28.
Cardarelli F, Bellasi A, Fang-Shu O, et al. Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry). Am J Cardiol. 2009;103(6):766–71.CrossRefPubMed
29.
Penko M, Bevc S, Kanič V, Hojs R. The prevalence of chronic kidney disease in patients with acute coronary syndrome. Zdrav Vestn. 2007;76(3):151–7.
30.
Ekart R, Hojs R, Bevc S, Balon BP. Asymptomatic atherosclerosis and hypertension in nondiabetic patients with chronic kidney disease. Artif Organs. 2007;32(3):220–5.CrossRef
31.
Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351(13):1285–95.CrossRefPubMed
32.
Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol. 2003;41(1):47–55.CrossRefPubMed
33.
Pahor D. 2012—European year for active ageing and solidarity between generations. Acta Medico-Biotechnica. 2011;4(2):7–10.
34.
Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC study. Kidney Int. 2003;64(2):610–5.CrossRefPubMed
35.
Iseki K, Tozawa M, Yoshi S, Fukiyama K. Serum C-reaktive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant. 1999;14(8):1956–60.CrossRefPubMed
36.
Zimmerman J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55(2):648–58.CrossRef
37.
Di Napoli M, Schwaninger M, Cappelli R, et al. Evaluation of C-reactive protein measurment for assessing the risk and prognosis in ischemic stroke. Stroke. 2005;36(6):1316–29.CrossRefPubMed
38.
Tanne D, Benderly M, Goldbourt U, et al. C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease. Stroke. 2006;37(7):1720–24.CrossRefPubMed
39.
Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int. 1999;55(5):1899–911.CrossRefPubMed
40.
Metadaten
Titel
Ischemic stroke: the impact of renal dysfunction on 1-year mortality
verfasst von
Assoc. Prof. Tanja Hojs Fabjan, MD, PhD
Prof. Radovan Hojs, MD, PhD
Publikationsdatum
01.12.2015
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe Sonderheft 5/2015
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-015-0705-y

Weitere Artikel der Sonderheft 5/2015

Attitudes of the Prekmurje Roma towards health and healthcare

  • original article

The role of the Director Zmago Slokan in the development of Maribor General Hospital in the first period after the Second World War (1953–1970)

  • editorial

Prevalence of isolated systolic hypertension (ISH) in Slovene hypertensive patients: insights from the “Quality of Healthcare in Slovenia” project

  • original article

Clinical and laboratory characteristics of viral lower respiratory tract infections in preschool children

  • original article

Partial skull base tumour resection in combination with radiosurgery: an escape procedure or a reasonable solution of treatment?

  • original article

Gender-related differences in patients with ST-elevation myocardial infarction

  • original article